InvestorsHub Logo
Followers 829
Posts 119663
Boards Moderated 16
Alias Born 09/05/2002

Re: None

Friday, 04/26/2024 9:45:52 AM

Friday, April 26, 2024 9:45:52 AM

Post# of 6149
FDA approves PFE’s Beqvez gene-therapy for hemophilia-B:

https://www.businesswire.com/news/home/20240425269649/en

The US list price of $3.5M is the same as CSL’s Hemgenix (#msg-170520619).

p.s. Benveq should not be confused with PFE's Marstacimab for hemophilia A and hemophilia B (#msg-172016370), which is an antibody, not a gene therapy.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News